Mohanjit Jolly

Currently Partner at Ironpillar. Over 15 years of global venture experience. Previously Partner at DFJ and Garage Technology Ventures.

[Freehand.ai @freehand_ai]

We saved $260M in cash for cos. like Meta, Unilever, and J&J by finding baseless charges across 19M+ invoices.

Now, we've raised $75M to extend our guarantee: if we can't find $500K in overpaid invoices, we'll pay you $10K.

Book a demo: https://t.co/FbUCc391D5

------------------------

How it works ⬇️

PROBLEM:

A Fortune 500 gets a million invoices a year. Most of them are for a couple hundred dollars.

Checking one properly means opening the contract, pulling the rate card, matching the PO, and hunting down the bill of lading that proves the shipment moved the way the carrier says it did.

All of that work to defend $200. So nobody does it.

The pile goes to a human. The human audits only a sample (12%) and pays the rest (88%) blindly. That's where the money goes.

At a pharma co, we found an uncontracted surcharge billed across global carriers for two years. $26M nobody questioned, because every individual line looked ordinary.

Each surcharge is small enough that escalating it costs more than paying it. And there are a million of them.

------------------------

SOLUTION:

Freehand’s AI reads everything: every line of every invoice, against every contract, rate card, transaction data, bill of lading, warehouse record, time sheet, and email exchange between you and the supplier. It also analyses every past invoice, and transaction data with that supplier,
ever.

It holds all of this knowledge in a Context Graph. When an invoice arrives, it knows what you should pay, what actually shipped, if the service was delivered or not, what the SLA was, and what this supplier billed you for the same service last quarter.

Then it proactively:

> writes up the dispute with the evidence attached
> emails the supplier
> calls her when the email goes quiet
> Slacks your purchases team for more information
> Follows up until the invoice comes back corrected.
> Approves the correct invoice
> Pays it across different currencies and tax structures
> And accrues the right amount to your general ledger

Freehand’s will do all of that to recover $20, because it is doing it across all millions of invoices at the same time, saving 5-10% of company spend with 100% SOX compliance and auditability.

-------------------------

🚨 RT + reply "FREEHAND" and we'll send you the AI upskilling guide that's already helped 750+ displaced workers move into more secure, higher-paying AI-native roles through Freehand's Transition Bootcamp.

[Mohanjit Jolly @jollymoh]

A boost for entrepreneurship in India, thanks to the second Startup India fund of funds to the tune of 10,000 Crores!!!

[Narendra Modi @narendramodi]

At Seva Teerth earlier today, signed files that are connected with the empowerment of the poor, downtrodden, our hardworking farmers, Yuva Shakti and Nari Shakti. The key decisions include:

Approval for the launch of PM RAHAT scheme, as per which victims of accidents will get cashless treatment of up to Rs. 1.5 lakhs. This will ensure that immediate medical help is provided to anyone affected.

Doubling of the target of the Lakhpati Didi scheme to 6 crore. This will boost women empowerment and self-reliance.

The Agriculture Infrastructure Fund target has been doubled from Rs. 1 lakh crore to Rs. 2 lakh crore. This will be immensely helpful to our farmers and help boost their incomes.

Approval for a Startup India Fund of Funds 2.0 with a corpus of Rs. 10,000 crore. This will encourage startups in early stages and deep-tech research.

These decisions reaffirm the spirit of Nagrikdevo Bhava and add momentum to our vision of building a Viksit Bharat.

[Vyome Holdings, Inc. @VyomeInc]

Malignant fungating wounds (MFWs) occur for 5–14% of advanced cancer patients in the United States.

They develop when tumors break through the skin, resulting in severe pain, malodor, and social isolation.

MFWs have begun to symbolize death for cancer patients and their families, and there are currently zero FDA-approved treatments for this painful condition.

$HIND

[Vyome Holdings, Inc. @VyomeInc]

Malignant Fungating Wounds (MFWs) occur in the last 6 months to 1 year of life for cancer patients.

They develop when tumors break through the skin, resulting in severe pain, malodor, and social isolation.

There are currently ZERO FDA-approved treatments for MFWs. $HIND

[Vyome Holdings, Inc. @VyomeInc]

Skin cancer affects 1 in 5 Americans in their lifetime.

While many cases are caught early, in advanced cases, Malignant Fungating Wounds (MFWs) can occur.

This happens when the cancer ulcerates and destroys the skin structure.

It transforms into a painful, open wound. $HIND

[Vyome Holdings, Inc. @VyomeInc]

Breast cancer is one of the most common diagnoses globally.

Unfortunately, for thousands of advanced patients globally, it evolves into a Malignant Fungating Wound.

This occurs when the tumor erupts through the skin, causing severe odor & social isolation. $HIND

[Vyome Holdings, Inc. @VyomeInc]

Cancer is the 2nd leading cause of death worldwide.

And for 15% of patients, the suffering doesn't stop at diagnosis.

When a tumor breaks through the surface of the skin, it becomes a Malignant Fungating Wound.

It strips patients of their dignity, causing severe odor and isolation, affecting MILLIONS. The industry has ignored this for decades.

[Vyome Holdings, Inc. @VyomeInc]

Read about Vyome's most recent clinical trial work: https://t.co/LKEBiLrGpa

#Biotech #JPM26 #Oncology

[Vyome Holdings, Inc. @VyomeInc]

Up to 15% of terminal cancer patients silently struggle from the social isolation caused by Malignant Fungating Wounds.

Untreated, malodor is detectable from 10 feet away.

After VT-1953 treatment, it is only detectable within 3 feet (and only after removing dressings). $HIND

[Mohanjit Jolly @jollymoh]

Delighted to announce ⁦@VyomeInc⁩’s acquisition of ⁦@oculohealth⁩! We are adding ammunition to address Inflammation as perhaps the largest health issue facing society today! https://t.co/N9L8QsHJ6E

[Venkat Nelabhotla @newvenkat]

Leadership boost at @VyomeInc (NASDAQ: $HIND)
Richard Fahrner (17+ FDA approvals; ex-Pfizer/Gilead/Sanofi) joins as CTO & Tamara Agajanov (ex-Roche/BI) as SVP Clinical Dev.

Their expertise strengthens Vyome’s progress in immuno-inflammatory programs.

#Biotech #NASDAQ #ClinicalDevelopment #investing @YahooFinance @Stocktwits

[Venkat Nelabhotla @newvenkat]

Just 6+ weeks since listing, @VyomeInc & $HIND have been busy — multiple initiatives advanced, milestones in motion, and strong comms through frequent press releases.

Management & Board are working hard on disciplined execution and long-term value creation. Fully capitalized with runway into last quarter of 2026.

#Biotech #Execution #Strategy #CapitalMarkets

[Venkat Nelabhotla @newvenkat]

Chronic inflammation affects hundreds of millions globally, driven by multiple causes. At @VyomeInc (#NASDAQ $HIND), we’re advancing innovative solutions for potentially rare indications of inflammation and exploring new possibilities.

#ChronicInflammation #Biotech #Innovation #GlobalHealth

[Mohanjit Jolly @jollymoh]

⁦⁦@VyomeInc⁩ continues to make strides!!!Vyome Holdings (Nasdaq:HIND) Announces Positive Interim Data from Phase 2 Study of VT-1953 in Malignant Fungating Wounds (MFW) and Provides Update on MFW market opportunity https://t.co/3tHeEyClQr

[Mohanjit Jolly @jollymoh]

@VyomeTx rang the opening bell on @Nasdaq today as it went public and started trading under the ticker $HIND. What an incredible milestone! Congratulations to the entire team! @ironpillarfund proud!

[Mohanjit Jolly @jollymoh]

Stay tuned for a detailed version of the @VyomeInc story, but this trailer of a conversation between @KrishnaKGupta and @shiladitya_sg provides a glimpse into the history and vision of the company from #India to the #US & soon to be on @Nasdaq trading as $HIND! $RSLS

[Krishna K. Gupta @KrishnaKGupta]

The Story of @VyomeInc - trailer launched today as we get closer to being on the Nasdaq. A very authentic conversation between @shiladitya_sg & me. Over the next few weeks we'll be launching a string of videos laying out the vision of $HIND ! $RSLS

[Vyome Holdings, Inc. @VyomeInc]

Unveiling our new logo! A powerful convergence of the US and India, and a commitment to create value for all stakeholders.

$RSLS $HIND

[Mohanjit Jolly @jollymoh]

Worth a read...Excited about the upcoming @VyomeTx milestone as it merges with $RSLS and will start trading under the ticker $HIND

From Delhi to Nasdaq: Vyome Ready to Launch a New Chapter as $HIND by Krishna Gupta https://t.co/iQQMp67pBF

[Mohanjit Jolly @jollymoh]

There are reasons Silicon Valley is special. But in this Volley, I insert a slightly personal lens on the topic....

Check out my latest article: Jolly's Volley: Only in Silicon Valley in The Age of AI https://t.co/BZSjyBSypn via @LinkedIn

[Vyome Holdings, Inc. @VyomeInc]

@Yahoo https://t.co/gPRFb3Nbqf